These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30567044)

  • 1. Comparison of Four MMPI-2 Validity Scales in Identifying Invalid Neurocognitive Dysfunction in Traumatic Brain Injury Litigants.
    Tsushima WT; Geling O; Woo A
    Appl Neuropsychol Adult; 2013; 20(4):263-271. PubMed ID: 30567044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting negative response bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2.
    Dionysus KE; Denney RL; Halfaker DA
    Arch Clin Neuropsychol; 2011 Mar; 26(2):81-8. PubMed ID: 21148668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MMPI-2 validity scale scores of personal injury litigants and disability claimants.
    Tsushima WT; Geling O; Fabrigas J
    Clin Neuropsychol; 2011 Nov; 25(8):1403-14. PubMed ID: 22003896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exaggerated MMPI-2 symptom report in personal injury litigants with malingered neurocognitive deficit.
    Larrabee GJ
    Arch Clin Neuropsychol; 2003 Aug; 18(6):673-86. PubMed ID: 14591440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the response bias scale (RBS) and other MMPI-2 validity scales in predicting TOMM performance.
    Whitney KA; Davis JJ; Shepard PH; Herman SM
    Arch Clin Neuropsychol; 2008; 23(7-8):777-86. PubMed ID: 18930375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the MMPI-2 restructured form (MMPI-2-RF) and malingered neurocognitive dysfunction among non-head injury disability claimants.
    Tarescavage AM; Wygant DB; Gervais RO; Ben-Porath YS
    Clin Neuropsychol; 2013; 27(2):313-35. PubMed ID: 23181937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A known-groups evaluation of the response bias scale in a neuropsychological setting.
    Sullivan KA; Elliott CD; Lange RT; Anderson DS
    Appl Neuropsychol Adult; 2013; 20(1):20-32. PubMed ID: 23373681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Henry-Heilbronner Index: a 15-item empirically derived MMPI-2 subscale for identifying probable malingering in personal injury litigants and disability claimants.
    Henry GK; Heilbronner RL; Mittenberg W; Enders C
    Clin Neuropsychol; 2006 Dec; 20(4):786-97. PubMed ID: 16980262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of the MMPI-2-RF Henry-Heilbronner Index-r (HHI-r) scale.
    Henry GK; Heilbronner RL; Algina J; Kaya Y
    Clin Neuropsychol; 2013; 27(3):509-15. PubMed ID: 23157160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the MMPI-2 Response Bias Scale and Henry-Heilbronner Index in a U.S. veteran population.
    Young JC; Kearns LA; Roper BL
    Arch Clin Neuropsychol; 2011 Apr; 26(3):194-204. PubMed ID: 21459900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the MMPI-3 over-reporting scales in a forensic disability sample.
    Tylicki JL; Gervais RO; Ben-Porath YS
    Clin Neuropsychol; 2022 Oct; 36(7):1878-1901. PubMed ID: 33319631
    [No Abstract]   [Full Text] [Related]  

  • 12. Does True Neurocognitive Dysfunction Contribute to Minnesota Multiphasic Personality Inventory-2nd Edition-Restructured Form Cognitive Validity Scale Scores?
    Martin PK; Schroeder RW; Heinrichs RJ; Baade LE
    Arch Clin Neuropsychol; 2015 Aug; 30(5):377-86. PubMed ID: 26051870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
    Jones A; Ingram MV
    Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutoff Scores for MMPI-2 and MMPI-2-RF Cognitive-Somatic Validity Scales for Psychometrically Defined Malingering Groups in a Military Sample.
    Jones A
    Arch Clin Neuropsychol; 2016 Nov; 31(7):786-801. PubMed ID: 27405640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of symptom exaggeration with the MMPI-2 in litigants with malingered neurocognitive dysfunction.
    Larrabee G
    Clin Neuropsychol; 2003 Feb; 17(1):54-68. PubMed ID: 12854011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the MMPI-2-RF for Detecting Over-reported Symptoms in a Civil Forensic and Disability Setting.
    Nguyen CT; Green D; Barr WB
    Clin Neuropsychol; 2015; 29(2):255-71. PubMed ID: 25905684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Lees-Haley Fake Bad Scale, Henry-Heilbronner Index, and restructured clinical scale 1 in identifying noncredible symptom reporting.
    Henry GK; Heilbronner RL; Mittenberg W; Enders C; Stanczak SR
    Clin Neuropsychol; 2008 Sep; 22(5):919-29. PubMed ID: 18756392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of MMPI-2 validity scales and indicators to malingered neurocognitive dysfunction in traumatic brain injury.
    Greve KW; Bianchini KJ; Love JM; Brennan A; Heinly MT
    Clin Neuropsychol; 2006 Sep; 20(3):491-512. PubMed ID: 16895861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent validation of the MMPI-2-RF Somatic/Cognitive and Validity scales in TBI Litigants tested for effort.
    Youngjohn JR; Wershba R; Stevenson M; Sturgeon J; Thomas ML
    Clin Neuropsychol; 2011 Apr; 25(3):463-76. PubMed ID: 21391149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in MMPI-2 FBS and RBS scores in brain injury, probable malingering, and conversion disorder groups: a preliminary study.
    Peck CP; Schroeder RW; Heinrichs RJ; Vondran EJ; Brockman CJ; Webster BK; Baade LE
    Clin Neuropsychol; 2013; 27(4):693-707. PubMed ID: 23510271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.